Immucell (ICCC) Change in Account Payables (2010 - 2014)
Immucell's (ICCC) quarterly Change in Account Payables came in at -$10547.0 in Q3 2014, up 86.45% on a YoY basis from -$5656.9 in Q3 2013, and down 59.56% quarter-over-quarter from -$6610.0 in Q2 2014.
Analysis
Immucell (ICCC) Change in Account Payables (2010 - 2014) Analysis & Trends
Immucell (ICCC) has reported Change in Account Payables for 5 consecutive years, with -$10547.0 the latest figure, recorded in Q3 2014.
- For the quarter ending Q3 2014, Change in Account Payables rose 86.45% year-over-year to -$10547.0; the trailing twelve-month figure through Sep 2014 stood at $39864.0 (up 155.66% YoY), and the FY2013 full-year result was -$95503.0, down 195.46% from the prior year.
- Change in Account Payables declined to -$10547.0 in Q3 2014 per ICCC's latest filing, from -$6610.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $79429.0 in Q1 2012 and bottomed at -$93350.0 in Q2 2012.
- Historically, Change in Account Payables has averaged $3233.5 across 5 years, with a median of $21992.0 in 2014.
- The sharpest annual moves came in 2011 and 2013: Change in Account Payables surged 139.69% in 2011, then slumped 241.33% in 2013.
- Over 5 years, Change in Account Payables stood at -$69877.0 in 2010, then soared by 139.69% to $27733.0 in 2011, then surged by 112.41% to $58909.0 in 2012, then tumbled by 40.54% to $35029.0 in 2013, then tumbled by 130.11% to -$10547.0 in 2014.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$10547.0, -$6610.0, and $21992.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | -6.74 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -53.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -5.65 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | -10,547.00 |
| Jun 30, 2014 | -6,610.00 |
| Mar 31, 2014 | 21,992.00 |
| Dec 31, 2013 | 35,029.00 |
| Sep 30, 2013 | -77,817.00 |
| Jun 30, 2013 | 15,795.00 |
| Mar 31, 2013 | -68,510.00 |
| Dec 31, 2012 | 58,909.00 |
| Sep 30, 2012 | 55,059.00 |
| Jun 30, 2012 | -93,350.00 |
| Mar 31, 2012 | 79,429.00 |
| Dec 31, 2011 | 27,733.00 |
| Sep 30, 2011 | 53,519.00 |
| Jun 30, 2011 | -66,716.00 |
| Mar 31, 2011 | 44,943.00 |
| Dec 31, 2010 | -69,877.00 |
| Sep 30, 2010 | 55,988.00 |